Notes
As Summer Begins, National Organization Helps Highlight Dangers of UV Overexposure
On Friday, May 28, the National Council on Skin Cancer Prevention sponsored the second annual “Don’t Fry Day,” a nationwide event held in advance of the Memorial Day weekend to encourage sun safety awareness and to remind people to protect their skin while enjoying the outdoors.
NCI is an advisory member of the Council, which is dedicated to reducing skin cancer morbidity and mortality in the United States by minimizing exposure to intense ultraviolet radiation.
To learn more about skin cancer prevention and other related research, please visit NCI’s Skin Cancer home page.
Meet NCI Experts at ASCO (Updated)
Learn about NCI’s programs and Web sites by visiting booth #2033 in the exhibit hall during the 2010 American Society of Clinical Oncology Annual Meeting, taking place June 4-8 in Chicago, Illinois. NCI experts will be available to talk about a wide range of topics (see schedule below). Also visit the NCI @ ASCO Web site for information about other NCI educational and special sessions taking place at the meeting.
Saturday, June 5
| 11:00 a.m. | AccrualNet Ellen Richmond and Linda Parreco |
| 12:00 p.m. | Funding for Biomarker, Imaging, & QOL Studies Associated with NCI’s Clinical Trials Geoffrey Seidel |
| 1:00 p.m. | NCI Online Course: Including Clinical Trials in Your Practice Rose Mary Padberg |
| 2:00 p.m. | Using TNF-alpha Antagonists to Treat Primary Tumor and Tumor Metastases Charles Rainwater |
| 3:00 p.m. | AccrualNet Holly Massett and Rose Mary Padberg |
| 4:00 p.m. | Cancer Training Branch Susan Lim |
Sunday, June 6
| 10:00 a.m. | NCI Online Course: Including Clinical Trials in Your Practice Linda Parreco |
| 11:00 a.m. | NCI’s Office of Cancer Complementary and Alternative Medicine Farrah Zia |
| 12:00 p.m. | Overview of Specialized Programs of Research Excellence (SPOREs) Rajeev Agarwal |
| 1:00 p.m. | NCI SBIR Funding for Small Startup Businesses to Bring Science to the Market Gregory Evans |
| 2:00 p.m. | Using TNF-alpha Antagonists to Treat Primary Tumor and Tumor Metastases Charles Rainwater |
| 3:00 p.m. | Funding for Biomarker, Imaging, & QOL Studies Associated with NCI’s Clinical Trials Geoffrey Seidel |
| 4:00 p.m. | Funding Opportunities to Promote Workplace Diversity John O. Ojeifo |
Monday, June 7
| 9:00 a.m. | Translations Research Program (SPOREs) Ivan Ding |
| 11:00 a.m. | Funding for Biomarker, Imaging, & QOL Studies Associated with NCI’s Clinical Trials Geoffrey Seidel |


